Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme

Abstract

The UK National Breast Screening Programme is planned to have the age range for invitation to screening expanded from 50—70 to 47—73. At the upper limit, this represents one additional screen taking place in the early 70s. We aimed to estimate the likely effect of this on breast cancer mortality and on overdiagnosis of breast cancer. We used estimates of breast cancer incidence and survival by detection mode (screening or symptomatic), screening lead time and mortality from competing causes to estimate the likely numbers of breast cancer deaths prevented per 1000 women screened, using both a stochastic continuous time model and a semi-deterministic discrete time model. In the continuous model, we estimated that per 1000 women screened 1.2 deaths would be prevented and in the discrete model 0.91 deaths. In the latter model, we also estimated that there would be around 6.8 years of life saved per 1000 women screened and an additional two diagnoses of breast cancer. These results suggest that the expansion of the upper age limit will be cost-effective. They remain to be confirmed by evaluation of the age extension. They provide prior estimates that may inform the evaluation of the age extension.

Get full access to this article

View all access options for this article.

References

Chen HH , Duffy SW , Tabar L. , Day NE Markov chain models for progression of breast cancer, part 1: tumour attributes and the preclinical screen-detectable phase. Journal of Epidemiology and Biostatistics 1997; 2: 9-23.

Yen MF , Tabar L. , Vitak B. , Smith RA , Chen HH , Duffy SW Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. European Journal of Cancer 2003; 39: 1746-54

Day NE , Walter SD Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984; 40: 1-13.

Office for National Statistics. Cancer statistics: registrations 2003. Her Majesty’s Stationery Office , London; 2005.

Office for National Statistics. Mortality statistics: cause 2004. Her Majesty’s Stationery Office, London; 2005.

Tabar L. , Vitak B. , Chen HH , Duffy SW , Smith RA The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long term follow-up. Radiologic Clinics of North America 2000; 38: 625-51.

Advisory Committee on Breast Cancer Screening. Screening for breast cancer in England: past and future . NHS Cancer Screening Programmes, Sheffield; 2006.

Pearson SD , Rawlins MD Quality, innovation and value for money: NICE and the British Health Service . Journal of the American Medical Association 2005; 294: 2618-22.

Bennett RL , Blanks RG , Moss SM Evaluation of extension of breast screening to women aged 65-70 in England using screening performance measures. British Journal of Cancer 2009; 100: 1043-7.